Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

appetite, the amount of food eaten, and body weight. These are not all the side effects with BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,700 employees nationwide.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that exenatide and the revenu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... LAKE CITY , Sept. 1, 2015 /PRNewswire/ ... that it will present at the First Annual ... in New York City.  Kelvyn H. Cullimore, ... present to leading institutional investment representatives on Tuesday, ... The Ladenburg Thalmann Conference will showcase leading-edge ...
(Date:9/1/2015)... VEGAS , Sept. 1, 2015  Dr. ... DigiPath Labs , the cannabis testing subsidiary of DigiPath, ... Patients Group about the lack of consistency in ... the online resource for medical cannabis information, she explained ... patients because their lack of uniform requirements makes standardization ...
(Date:9/1/2015)... , Sept. 1, 2015  Edwards Lifesciences Corporation ... science of heart valves and hemodynamic monitoring, is scheduled ... Conference at the Hyatt Regency Boston in ... Michael A. Mussallem , Edwards Lifesciences, ... speaker followed by a company discussion with conference attendees ...
Breaking Medicine Technology:DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3
... 2012 /PRNewswire-Asia/ -- As the whole world battles against cancer, ... a great improvement. Cancer is still the number one cause ... patients have, in recent times, managed to survive for more ... are available in Korea. The Korean government recently ...
... TeDan Surgical Innovations , industry leader in surgical ... Series MIS Anterior Hip Retractor System . TeDan Surgical,s ... arms with attachable retractors, enabling surgeons to perform the ... assistant. Dr. Lawrence Menendez and Dr. ...
Cached Medicine Technology:Survival Rate of Cancer Patients in Korea Ranked in the Top in the World 2New Minimally Invasive Hip Retractor Revolutionizes Anterior Hip Replacement Procedures 2
(Date:9/1/2015)... ... September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ...
(Date:9/1/2015)... Angeles, CA (PRWEB) , ... September 01, 2015 , ... ... American Medical Association, individuals with type 2 diabetes that participated in a three year ... diabetes three years down the line if they elected weight loss surgery at the ...
(Date:9/1/2015)... ... , ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive session of ... has taken place at Kingsborough Community College in Brooklyn in each of the past ... Calvary, and two junior counselors who were campers themselves just a few years ago. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer ... for Dermatologic Surgery, according to a new survey that also offers insight on ... Dermatologic Procedures – which reflects views on cosmetic medical treatments and ratings for ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, TX ... , an innovative vaginal health laser procedure that prevents and resolves dryness in ... atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse and ...
Breaking Medicine News(10 mins):Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3
... , TUESDAY, May 15 (HealthDay News) -- Black ... develop precancerous colorectal polyps, a new study finds. Researchers ... 50 and older who had a first-time colonoscopy screening at ... between 2006 and 2010. None of the patients had signs ...
... May 15 (HealthDay News) -- Researchers are preparing to test ... disease. The best-scenario hope is that the drug will ... and to a better understanding of its destructive processes, U.S. ... some Americans as well as 300 members of an extended ...
... TUESDAY, May 15 (HealthDay News) -- The lives of more ... 2004 and 2008 by the U.S. President,s Emergency Plan for ... adults, risk of death from all causes by 16 percent ... of Medicine researchers found. The researchers said this is the ...
... (HealthDay News) -- "Team-based care" should be used to ... on Community Preventive Services recommended on Tuesday. The ... that showed improvements in patients, control of blood pressure ... professionals -- a primary care doctor supported by a ...
... undergo radical surgery for prostate cancer may expect better ... hospitals with residency programs, and better still if the ... study by Henry Ford Hospital. The study, which ... throughout the U.S., also found that those with fewer ...
... Older, sicker, high-risk patients who undergo one of the ... in larger, busier hospitals, according to new research by ... research showed the experience level of the surgeon doing ... The results, based on data gathered throughout the ...
Cached Medicine News:Health News:Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought 2Health News:Trial Set to See if Drug Can Prevent Alzheimer's 2Health News:U.S. Task Force Issues Blood Pressure Guidelines 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2
Ergotec Vetriretinal Instrument System. 2 mm pointed tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Angled shafts with 12 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left. Most popular size or model....
Angled shafts with 9 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left....
Angled 13.5 mm adjustable blades. Teeth in lower jaws fit into holes in upper jaws. Grooves in lower jaw for passage of suture needles. Round knurled handle with polished finish....
Medicine Products: